GW Pharmaceuticals Announces Research & Development Management Appointments
May 15, 2017 11:02 am UTC| Business
– Dr. Volker Knappertz appointed Chief Medical Officer –– Professor Ben Whalley to join as Head of Discovery Research – LONDON, May 15, 2017 -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a...
GW Pharmaceuticals Announces Research & Development Management Appointments
May 15, 2017 11:02 am UTC| Business
– Dr. Volker Knappertz appointed Chief Medical Officer –– Professor Ben Whalley to join as Head of Discovery Research – LONDON, May 15, 2017 -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a...
May 15, 2017 11:02 am UTC| Business
MALVERN, Pa., May 15, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that clinical...
May 15, 2017 11:02 am UTC| Business
SALT LAKE CITY, May 15, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that holders of the 2017 Series B Senior Secured Convertible Notes (the “Series B Notes”) have...
May 15, 2017 11:02 am UTC| Business
SALT LAKE CITY, May 15, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that holders of the 2017 Series B Senior Secured Convertible Notes (the “Series B Notes”) have...
May 15, 2017 11:02 am UTC| Business
MALVERN, Pa., May 15, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that clinical...
May 15, 2017 11:02 am UTC| Business
MALVERN, Pa., May 15, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that clinical...